Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties.

Subjects

Subjects :

Adenylyl Cyclase Inhibitors
Animals
Catecholamines metabolism
Corpus Striatum enzymology
Homovanillic Acid metabolism
In Vitro Techniques
Limbic System enzymology
Male
Piperazines pharmacology
Rats
Time Factors
Antipsychotic Agents pharmacology
Corpus Striatum metabolism
Dopamine metabolism
Limbic System metabolism
Pyrimidines pharmacology

Details

Language :

English

ISSN :

0024-3205

Volume :

23

Issue :

3

Database :

MEDLINE

Journal :

Life sciences

Publication Type :

Academic Journal

Accession number :

29181

Full Text :

https://doi.org/10.1016/0024-3205(78)90314-4